 | • レポートコード：QYR2104Z0521 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、自己免疫疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、抗炎症薬、コルチコステロイド、非ステロイド性抗炎症薬、生物製剤）、用途別市場規模（病院、クリニック、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・自己免疫疾患治療の市場動向 ・企業の競争状況、市場シェア ・自己免疫疾患治療の種類別市場規模（免疫抑制剤、抗炎症薬、コルチコステロイド、非ステロイド性抗炎症薬、生物製剤） ・自己免疫疾患治療の用途別市場規模（病院、クリニック、ドラッグストア、その他） ・自己免疫疾患治療の北米市場規模2016-2027（アメリカ、カナダ） ・自己免疫疾患治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・自己免疫疾患治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・自己免疫疾患治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・自己免疫疾患治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Active Biotech、Eli Lilly、Bristol-Myers Squibb、AstraZeneca plc、Pfizer、Biogen Idec、Lupin Limited、GlaxoSmithKline、Amgen、4SC AG、F. Hoffmann-La Roche Ltd.、AutoImmune Inc、Johnson & Johnson、Bayer） ・結論 |
Autoimmune diseases is a body’s hyperactive immune response against the substances and tissues normally present in the body. Autoimmune diseases are more commonly caused by genetic, infectious or environmental factors.
Market Analysis and Insights: Global Autoimmune Disease Treatment Market
The global Autoimmune Disease Treatment market size is projected to reach US$ 116550 million by 2026, from US$ 98660 million in 2019, at a CAGR of 2.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Autoimmune Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Autoimmune Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Autoimmune Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Autoimmune Disease Treatment market.
Global Autoimmune Disease Treatment Scope and Market Size
Autoimmune Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Immunosuppressant’s
Anti-Inflammatory Drugs
Corticosteroids
Nonsteroidal anti-inflammatory drugs
Biologics
Segment by Application
Hospitals
Clinics
Drug Stores
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Active Biotech
Eli Lilly
Bristol-Myers Squibb
AstraZeneca plc
Pfizer
Biogen Idec
Lupin Limited
GlaxoSmithKline
Bristol-Myers Squibb
AstraZeneca plc
F. Hoffmann-La Roche Ltd.
AutoImmune Inc
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunosuppressant’s
1.2.3 Anti-Inflammatory Drugs
1.2.4 Corticosteroids
1.2.5 Nonsteroidal anti-inflammatory drugs
1.2.6 Biologics
1.3 Market by Application
1.3.1 Global Autoimmune Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drug Stores
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Disease Treatment Market Perspective (2016-2027)
2.2 Autoimmune Disease Treatment Growth Trends by Regions
2.2.1 Autoimmune Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Autoimmune Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Autoimmune Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Autoimmune Disease Treatment Industry Dynamic
2.3.1 Autoimmune Disease Treatment Market Trends
2.3.2 Autoimmune Disease Treatment Market Drivers
2.3.3 Autoimmune Disease Treatment Market Challenges
2.3.4 Autoimmune Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Disease Treatment Players by Revenue
3.1.1 Global Top Autoimmune Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Autoimmune Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Autoimmune Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Disease Treatment Revenue
3.4 Global Autoimmune Disease Treatment Market Concentration Ratio
3.4.1 Global Autoimmune Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Treatment Revenue in 2020
3.5 Autoimmune Disease Treatment Key Players Head office and Area Served
3.6 Key Players Autoimmune Disease Treatment Product Solution and Service
3.7 Date of Enter into Autoimmune Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Disease Treatment Breakdown Data by Type
4.1 Global Autoimmune Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Autoimmune Disease Treatment Forecasted Market Size by Type (2022-2027)
5 Autoimmune Disease Treatment Breakdown Data by Application
5.1 Global Autoimmune Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Autoimmune Disease Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Autoimmune Disease Treatment Market Size (2016-2027)
6.2 North America Autoimmune Disease Treatment Market Size by Type
6.2.1 North America Autoimmune Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Autoimmune Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Autoimmune Disease Treatment Market Size by Type (2016-2027)
6.3 North America Autoimmune Disease Treatment Market Size by Application
6.3.1 North America Autoimmune Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Autoimmune Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Autoimmune Disease Treatment Market Size by Application (2016-2027)
6.4 North America Autoimmune Disease Treatment Market Size by Country
6.4.1 North America Autoimmune Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Autoimmune Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Autoimmune Disease Treatment Market Size (2016-2027)
7.2 Europe Autoimmune Disease Treatment Market Size by Type
7.2.1 Europe Autoimmune Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Autoimmune Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Autoimmune Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Autoimmune Disease Treatment Market Size by Application
7.3.1 Europe Autoimmune Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Autoimmune Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Autoimmune Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Autoimmune Disease Treatment Market Size by Country
7.4.1 Europe Autoimmune Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Autoimmune Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Autoimmune Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Autoimmune Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Autoimmune Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Autoimmune Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Autoimmune Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Autoimmune Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Autoimmune Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Autoimmune Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Autoimmune Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Autoimmune Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Autoimmune Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Autoimmune Disease Treatment Market Size (2016-2027)
9.2 Latin America Autoimmune Disease Treatment Market Size by Type
9.2.1 Latin America Autoimmune Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Autoimmune Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Autoimmune Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Autoimmune Disease Treatment Market Size by Application
9.3.1 Latin America Autoimmune Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Autoimmune Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Autoimmune Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Autoimmune Disease Treatment Market Size by Country
9.4.1 Latin America Autoimmune Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Autoimmune Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Autoimmune Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Autoimmune Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Autoimmune Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Autoimmune Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Autoimmune Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Autoimmune Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Autoimmune Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Autoimmune Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Autoimmune Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Autoimmune Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Autoimmune Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Autoimmune Disease Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Autoimmune Disease Treatment Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Active Biotech
11.2.1 Active Biotech Company Details
11.2.2 Active Biotech Business Overview
11.2.3 Active Biotech Autoimmune Disease Treatment Introduction
11.2.4 Active Biotech Revenue in Autoimmune Disease Treatment Business (2016-2021)
11.2.5 Active Biotech Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Autoimmune Disease Treatment Introduction
11.3.4 Eli Lilly Revenue in Autoimmune Disease Treatment Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Autoimmune Disease Treatment Introduction
11.4.4 Bristol-Myers Squibb Revenue in Autoimmune Disease Treatment Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 AstraZeneca plc
11.5.1 AstraZeneca plc Company Details
11.5.2 AstraZeneca plc Business Overview
11.5.3 AstraZeneca plc Autoimmune Disease Treatment Introduction
11.5.4 AstraZeneca plc Revenue in Autoimmune Disease Treatment Business (2016-2021)
11.5.5 AstraZeneca plc Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Autoimmune Disease Treatment Introduction
11.6.4 Pfizer Revenue in Autoimmune Disease Treatment Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Biogen Idec
11.7.1 Biogen Idec Company Details
11.7.2 Biogen Idec Business Overview
11.7.3 Biogen Idec Autoimmune Disease Treatment Introduction
11.7.4 Biogen Idec Revenue in Autoimmune Disease Treatment Business (2016-2021)
11.7.5 Biogen Idec Recent Development
11.8 Lupin Limited
11.8.1 Lupin Limited Company Details
11.8.2 Lupin Limited Business Overview
11.8.3 Lupin Limited Autoimmune Disease Treatment Introduction
11.8.4 Lupin Limited Revenue in Autoimmune Disease Treatment Business (2016-2021)
11.8.5 Lupin Limited Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Autoimmune Disease Treatment Introduction
11.9.4 GlaxoSmithKline Revenue in Autoimmune Disease Treatment Business (2016-2021)
11.9.5 GlaxoSmithKline Recent Development
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Amgen Business Overview
11.10.3 Amgen Autoimmune Disease Treatment Introduction
11.10.4 Amgen Revenue in Autoimmune Disease Treatment Business (2016-2021)
11.10.5 Amgen Recent Development
11.11 4SC AG
11.11.1 4SC AG Company Details
11.11.2 4SC AG Business Overview
11.11.3 4SC AG Autoimmune Disease Treatment Introduction
11.11.4 4SC AG Revenue in Autoimmune Disease Treatment Business (2016-2021)
11.11.5 4SC AG Recent Development
11.12 F. Hoffmann-La Roche Ltd.
11.12.1 F. Hoffmann-La Roche Ltd. Company Details
11.12.2 F. Hoffmann-La Roche Ltd. Business Overview
11.12.3 F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Introduction
11.12.4 F. Hoffmann-La Roche Ltd. Revenue in Autoimmune Disease Treatment Business (2016-2021)
11.12.5 F. Hoffmann-La Roche Ltd. Recent Development
11.13 AutoImmune Inc
11.13.1 AutoImmune Inc Company Details
11.13.2 AutoImmune Inc Business Overview
11.13.3 AutoImmune Inc Autoimmune Disease Treatment Introduction
11.13.4 AutoImmune Inc Revenue in Autoimmune Disease Treatment Business (2016-2021)
11.13.5 AutoImmune Inc Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Details
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Autoimmune Disease Treatment Introduction
11.14.4 Johnson & Johnson Revenue in Autoimmune Disease Treatment Business (2016-2021)
11.14.5 Johnson & Johnson Recent Development
11.15 Bayer
11.15.1 Bayer Company Details
11.15.2 Bayer Business Overview
11.15.3 Bayer Autoimmune Disease Treatment Introduction
11.15.4 Bayer Revenue in Autoimmune Disease Treatment Business (2016-2021)
11.15.5 Bayer Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Autoimmune Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunosuppressant’s
Table 3. Key Players of Anti-Inflammatory Drugs
Table 4. Key Players of Corticosteroids
Table 5. Key Players of Nonsteroidal anti-inflammatory drugs
Table 6. Key Players of Biologics
Table 7. Global Autoimmune Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Autoimmune Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Autoimmune Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Autoimmune Disease Treatment Market Share by Regions (2016-2021)
Table 11. Global Autoimmune Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Autoimmune Disease Treatment Market Share by Regions (2022-2027)
Table 13. Autoimmune Disease Treatment Market Trends
Table 14. Autoimmune Disease Treatment Market Drivers
Table 15. Autoimmune Disease Treatment Market Challenges
Table 16. Autoimmune Disease Treatment Market Restraints
Table 17. Global Autoimmune Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Autoimmune Disease Treatment Market Share by Players (2016-2021)
Table 19. Global Top Autoimmune Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Treatment as of 2020)
Table 20. Ranking of Global Top Autoimmune Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Autoimmune Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Autoimmune Disease Treatment Product Solution and Service
Table 24. Date of Enter into Autoimmune Disease Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Autoimmune Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Autoimmune Disease Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Autoimmune Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Autoimmune Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Autoimmune Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Autoimmune Disease Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Autoimmune Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Autoimmune Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Autoimmune Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Autoimmune Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Autoimmune Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Autoimmune Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Autoimmune Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Autoimmune Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Autoimmune Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Autoimmune Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Autoimmune Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Autoimmune Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Autoimmune Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Autoimmune Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Autoimmune Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Autoimmune Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Autoimmune Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Autoimmune Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Autoimmune Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Autoimmune Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Autoimmune Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Autoimmune Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Autoimmune Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Autoimmune Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Autoimmune Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Autoimmune Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Autoimmune Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Autoimmune Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Autoimmune Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Autoimmune Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Autoimmune Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Autoimmune Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Laboratories Company Details
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Autoimmune Disease Treatment Product
Table 67. Abbott Laboratories Revenue in Autoimmune Disease Treatment Business (2016-2021) & (US$ Million)
Table 68. Abbott Laboratories Recent Development
Table 69. Active Biotech Company Details
Table 70. Active Biotech Business Overview
Table 71. Active Biotech Autoimmune Disease Treatment Product
Table 72. Active Biotech Revenue in Autoimmune Disease Treatment Business (2016-2021) & (US$ Million)
Table 73. Active Biotech Recent Development
Table 74. Eli Lilly Company Details
Table 75. Eli Lilly Business Overview
Table 76. Eli Lilly Autoimmune Disease Treatment Product
Table 77. Eli Lilly Revenue in Autoimmune Disease Treatment Business (2016-2021) & (US$ Million)
Table 78. Eli Lilly Recent Development
Table 79. Bristol-Myers Squibb Company Details
Table 80. Bristol-Myers Squibb Business Overview
Table 81. Bristol-Myers Squibb Autoimmune Disease Treatment Product
Table 82. Bristol-Myers Squibb Revenue in Autoimmune Disease Treatment Business (2016-2021) & (US$ Million)
Table 83. Bristol-Myers Squibb Recent Development
Table 84. AstraZeneca plc Company Details
Table 85. AstraZeneca plc Business Overview
Table 86. AstraZeneca plc Autoimmune Disease Treatment Product
Table 87. AstraZeneca plc Revenue in Autoimmune Disease Treatment Business (2016-2021) & (US$ Million)
Table 88. AstraZeneca plc Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Autoimmune Disease Treatment Product
Table 92. Pfizer Revenue in Autoimmune Disease Treatment Business (2016-2021) & (US$ Million)
Table 93. Pfizer Recent Development
Table 94. Biogen Idec Company Details
Table 95. Biogen Idec Business Overview
Table 96. Biogen Idec Autoimmune Disease Treatment Product
Table 97. Biogen Idec Revenue in Autoimmune Disease Treatment Business (2016-2021) & (US$ Million)
Table 98. Biogen Idec Recent Development
Table 99. Lupin Limited Company Details
Table 100. Lupin Limited Business Overview
Table 101. Lupin Limited Revenue in Autoimmune Disease Treatment Business (2016-2021) & (US$ Million)
Table 102. Lupin Limited Recent Development
Table 103. GlaxoSmithKline Company Details
Table 104. GlaxoSmithKline Business Overview
Table 105. GlaxoSmithKline Autoimmune Disease Treatment Product
Table 106. GlaxoSmithKline Revenue in Autoimmune Disease Treatment Business (2016-2021) & (US$ Million)
Table 107. GlaxoSmithKline Recent Development
Table 108. Amgen Company Details
Table 109. Amgen Business Overview
Table 110. Amgen Autoimmune Disease Treatment Product
Table 111. Amgen Revenue in Autoimmune Disease Treatment Business (2016-2021) & (US$ Million)
Table 112. Amgen Recent Development
Table 113. 4SC AG Company Details
Table 114. 4SC AG Business Overview
Table 115. 4SC AG Autoimmune Disease Treatment Product
Table 116. 4SC AG Revenue in Autoimmune Disease Treatment Business (2016-2021) & (US$ Million)
Table 117. 4SC AG Recent Development
Table 118. F. Hoffmann-La Roche Ltd. Company Details
Table 119. F. Hoffmann-La Roche Ltd. Business Overview
Table 120. F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Product
Table 121. F. Hoffmann-La Roche Ltd. Revenue in Autoimmune Disease Treatment Business (2016-2021) & (US$ Million)
Table 122. F. Hoffmann-La Roche Ltd. Recent Development
Table 123. AutoImmune Inc Company Details
Table 124. AutoImmune Inc Business Overview
Table 125. AutoImmune Inc Autoimmune Disease Treatment Product
Table 126. AutoImmune Inc Revenue in Autoimmune Disease Treatment Business (2016-2021) & (US$ Million)
Table 127. AutoImmune Inc Recent Development
Table 128. Johnson & Johnson Company Details
Table 129. Johnson & Johnson Business Overview
Table 130. Johnson & Johnson Autoimmune Disease Treatment Product
Table 131. Johnson & Johnson Revenue in Autoimmune Disease Treatment Business (2016-2021) & (US$ Million)
Table 132. Johnson & Johnson Recent Development
Table 133. Bayer Company Details
Table 134. Bayer Business Overview
Table 135. Bayer Autoimmune Disease Treatment Product
Table 136. Bayer Revenue in Autoimmune Disease Treatment Business (2016-2021) & (US$ Million)
Table 137. Bayer Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Immunosuppressant’s Features
Figure 3. Anti-Inflammatory Drugs Features
Figure 4. Corticosteroids Features
Figure 5. Nonsteroidal anti-inflammatory drugs Features
Figure 6. Biologics Features
Figure 7. Global Autoimmune Disease Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Drug Stores Case Studies
Figure 11. Other Case Studies
Figure 12. Autoimmune Disease Treatment Report Years Considered
Figure 13. Global Autoimmune Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Autoimmune Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Autoimmune Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Autoimmune Disease Treatment Market Share by Regions (2022-2027)
Figure 17. Global Autoimmune Disease Treatment Market Share by Players in 2020
Figure 18. Global Top Autoimmune Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Autoimmune Disease Treatment Revenue in 2020
Figure 20. Global Autoimmune Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Autoimmune Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Autoimmune Disease Treatment Market Share by Type (2016-2027)
Figure 24. North America Autoimmune Disease Treatment Market Share by Application (2016-2027)
Figure 25. North America Autoimmune Disease Treatment Market Share by Country (2016-2027)
Figure 26. United States Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Autoimmune Disease Treatment Market Share by Type (2016-2027)
Figure 30. Europe Autoimmune Disease Treatment Market Share by Application (2016-2027)
Figure 31. Europe Autoimmune Disease Treatment Market Share by Country (2016-2027)
Figure 32. Germany Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Autoimmune Disease Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Autoimmune Disease Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Autoimmune Disease Treatment Market Share by Region (2016-2027)
Figure 42. China Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Autoimmune Disease Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Autoimmune Disease Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Autoimmune Disease Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Autoimmune Disease Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Autoimmune Disease Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Autoimmune Disease Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Autoimmune Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Abbott Laboratories Revenue Growth Rate in Autoimmune Disease Treatment Business (2016-2021)
Figure 62. Active Biotech Revenue Growth Rate in Autoimmune Disease Treatment Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Autoimmune Disease Treatment Business (2016-2021)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Autoimmune Disease Treatment Business (2016-2021)
Figure 65. AstraZeneca plc Revenue Growth Rate in Autoimmune Disease Treatment Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Autoimmune Disease Treatment Business (2016-2021)
Figure 67. Biogen Idec Revenue Growth Rate in Autoimmune Disease Treatment Business (2016-2021)
Figure 68. Lupin Limited Revenue Growth Rate in Autoimmune Disease Treatment Business (2016-2021)
Figure 69. GlaxoSmithKline Revenue Growth Rate in Autoimmune Disease Treatment Business (2016-2021)
Figure 70. Amgen Revenue Growth Rate in Autoimmune Disease Treatment Business (2016-2021)
Figure 71. 4SC AG Revenue Growth Rate in Autoimmune Disease Treatment Business (2016-2021)
Figure 72. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Autoimmune Disease Treatment Business (2016-2021)
Figure 73. AutoImmune Inc Revenue Growth Rate in Autoimmune Disease Treatment Business (2016-2021)
Figure 74. Johnson & Johnson Revenue Growth Rate in Autoimmune Disease Treatment Business (2016-2021)
Figure 75. Bayer Revenue Growth Rate in Autoimmune Disease Treatment Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界の自己免疫疾患治療市場 2021：企業別、地域別、種類・用途別 The Autoimmune Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…- 世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Autoimmune Disease Therapeutics Market The global Autoimmune Disease Therapeutics market size is projected to reach US$ 116550 million by 2026, from US$ 98660 million in 2019, at a CAGR of 2.4% during 2021-2026. With industry-standard accuracy in analysis and hig…
- 世界の非ステロイド性抗炎症薬（NSAID）市場規模・現状・予測（2021年-2027年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 世界の炎症性腸疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Inflammatory Bowel Disease Therapeutics Market The global Inflammatory Bowel Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
- 世界の炎症性腸疾患（IBD）治療市場規模・現状・予測（2021年-2027年） Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes t…